×
Nutriband Total Assets 2016-2024 | NTRB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nutriband total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Nutriband Total Assets 2016-2024 | NTRB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nutriband total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$80.4B
Zoetis (ZTS)
$70.5B
Takeda Pharmaceutical (TAK)
$44.1B
Daiichi Sankyo, - (DSNKY)
$43.3B
Sandoz Group AG (SDZNY)
$20.6B
Merck (MKKGY)
$18.5B
Astellas Pharma (ALPMY)
$17.5B
Summit Therapeutics (SMMT)
$17B
United Therapeutics (UTHR)
$16.4B
Shionogi (SGIOY)
$12.3B
Neurocrine Biosciences (NBIX)
$11.6B
Orion OYJ (ORINY)
$7.7B
Madrigal Pharmaceuticals (MDGL)
$7.7B
Corcept Therapeutics (CORT)
$6.8B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Stevanato Group S.p.A (STVN)
$6.2B
Ionis Pharmaceuticals (IONS)
$5.2B
Grifols, S.A (GRFS)
$5.2B
Ono Pharmaceutical (OPHLF)
$4.7B
Recursion Pharmaceuticals (RXRX)
$4B
Crinetics Pharmaceuticals (CRNX)
$3.4B
Catalyst Pharmaceuticals (CPRX)
$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.4B
Centessa Pharmaceuticals (CNTA)
$2.2B
Hypermarcas (HYPMY)
$2.2B
Soleno Therapeutics (SLNO)
$2B
BioCryst Pharmaceuticals (BCRX)
$1.9B
NewAmsterdam Pharma (NAMS)
$1.8B
Evotec AG (EVO)
$1.6B
Dyne Therapeutics (DYN)
$1.4B